Portulaca oleracea is as a medicinal plant known for its neuroprotective, hepatoprotective, antidiabetic, antioxidant, anticancer, antimicrobial, antiulcerogenic, and anti-inflammatory activities. However, the specific active compounds responsible for the individual pharmacological effects of P. oleracea extract (95% EtOH) remain unknown. Here, we hypothesized that alkaloids, the most abundant constituents in P. oleracea extract, are responsible for its anti-inflammatory activity. We investigated the phytochemical substituents (compounds 1-22) using nuclear magnetic resonance (NMR) and electrospray ionization mass spectrometry (ESI-MS) and screened their effects on NO production in lipopolysaccharide (LPS)-induced macrophages. Compound 20, 1-carbomethoxy-β-carboline, as an alkaloid structure, ameliorated nitric oxide (NO) production, inducible nitric oxide synthase (iNOS), and proinflammatory cytokines associated with the mitogen-activated protein kinase (MAPK) pathways, p38, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK). Subsequently, we observed that compound 20 suppressed nuclear translocation of nuclear factor κB (NF-κB) using immunocytochemistry. Moreover, we recently reported that compound 8, trans-N-feruloyl-3', 7'-dimethoxytyramine, was originally purified from P. oleracea extracts. Our results suggest that 1-carbomethoxy-β-carboline, the most effective anti-inflammatory agent among alkaloids in the 95% EtOH extract of P. oleracea, was suppressing the MAPK pathway and nuclear translocation of NF-κB. Therefore, P. oleracea extracts and specifically 1-carbomethoxy-β-carboline may be novel therapeutic candidates for the treatment of inflammatory diseases associated with the activation of MAPKs and NF-κB.
(HMBC), heteronuclear multiple quantum correlation (HMQC), high resolution electrospray ionization mass spectrometry (HRESIMS), infrared (IR) spectroscopy, and polarimetry techniques. By comparing the NMR data of the isolated compounds with data reported in the literature, the known compounds were identified as trans-N-courmaroyltyramine (1) [19] , trans-N-feruloyloctopamine (2) [20] , trans-N-feruloyltyramine (3) [19] , (7'S)-trans-N-feruloyloctopamine (4) [21] , (S)-3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)-2-methoxyethyl)-acrylamide (5) [22] , trans-N-feruloyl-3'-methoxytyramine (6) [21] , (7'S)-trans-N-feruloylnormetanephrine (7) [21] , N-trans-hibiscusamide (9) [21] , perillascens (10) [23] , aurantiamide acetate (11) [24] , methyl N-acetylphenylalaninate (12) [25] , N-benzoyl-l-aspartic acid dimethyl ester (13) [26] , N-benzoyl-d-aspartic acid dimethyl ester (14) [26] , scinamide C (15) [27] , oleracein E (16) [28] , methyl hematinate (17) [29] , 3-formylindole (18) [30] , 3-propionylindole (19) [30] , 1-carbomethoxy-beta-carboline (20) [11] , methyl pyroglutamate (21) [31] , and ethyl pyroglutamate (22) [32] .
Molecules 2019, 24, 4042 3 of 14 1 H correlated spectroscopy (COSY), heteronuclear multiple bond correlation (HMBC), heteronuclear multiple quantum correlation (HMQC), high resolution electrospray ionization mass spectrometry (HRESIMS), infrared (IR) spectroscopy, and polarimetry techniques. By comparing the NMR data of the isolated compounds with data reported in the literature, the known compounds were identified as trans-N-courmaroyltyramine (1) [19] , trans-N-feruloyloctopamine (2) [20] , trans-Nferuloyltyramine (3) [19] , (7'S)-trans-N-feruloyloctopamine (4) [21] , (S)-3-(4-hydroxy-3methoxyphenyl)-N-(2-(4-hydroxyphenyl)-2-methoxyethyl)-acrylamide (5) [22] , trans-N-feruloyl-3'methoxytyramine (6) [21] , (7'S)-trans-N-feruloylnormetanephrine (7) [21] , N-trans-hibiscusamide (9) [21] , perillascens (10) [23] , aurantiamide acetate (11) [24] , methyl N-acetylphenylalaninate (12) [25] , N-benzoyl-L-aspartic acid dimethyl ester (13) [26] , N-benzoyl-D-aspartic acid dimethyl ester (14) [26] , scinamide C (15) [27] , oleracein E (16) [28] , methyl hematinate (17) [29] , 3-formylindole (18) [30] , 3propionylindole (19) [30], 1-carbomethoxy-beta-carboline (20) [11] , methyl pyroglutamate (21) [31] , and ethyl pyroglutamate (22) [32] . Additionally, we newly isolated compound 8, as a yellowish oil ( Figure 2) . A molecular formula of C20H23NO6 was determined based on its HRESIMS spectrum and was deduced from ion peak at m/z 396.1423 [M + Na] + (396.1423, calcd for C20H23O6Na, Figure S1 ). The ultraviolet (UV) spectrum showed absorption peaks at 200, 227, 283, and 320 nm. The IR spectrum suggested the presence of OH groups, as indicated by a wide band at 3356 cm -1 and an amide carbonyl, as indicated by bands at 1737 cm -1 and 1653 cm -1 ( Figure S2 ). The 1 H NMR spectrum exhibited signals for three methoxy groups at δH 3.89 (3H, s, OCH3-3), 3 .86 (3H, s, OCH3-3'), and 3.24 (3H, s, OCH3-7'); two olefinic protons at δH 7.44 (1H, d, J = 15.6 Hz, H-7) and 6.45 (1H, d, J = 15.6 Hz, H-8); two ABX aromatic ring protons at δH 7.13 (1H, d, J = 1.8 Hz, H-2), 7.03 (1H, dd, J = 8.4, 1.8 Hz, H-6), 6 .92 (1H, s), and 6.80 (3H, overlap); Additionally, we newly isolated compound 8, as a yellowish oil ( Figure 2) . A molecular formula of C 20 H 23 NO 6 was determined based on its HRESIMS spectrum and was deduced from ion peak at m/z 396.1423 [M + Na] + (396.1423, calcd for C 20 H 23 O 6 Na, Figure S1 ). The ultraviolet (UV) spectrum showed absorption peaks at 200, 227, 283, and 320 nm. The IR spectrum suggested the presence of OH groups, as indicated by a wide band at 3356 cm −1 and an amide carbonyl, as indicated by bands at 1737 cm −1 and 1653 cm −1 ( Figure S2 Figure S3 ). The 13 C NMR spectrum showed 20 resonances, which were classified as three methoxy carbons, sp 2 carbon signals corresponding to two benzene rings, one carbonyl, one methylene, one methane, and one alkyne ( Figure S4) . These proton and carbon assignments were further confirmed by detailed analysis of the 1 H-1 H COSY, HMQC, and HMBC spectra. The 1 H-1 H COSY spectrum showed correlations of H-7/H-8, H-7'/H-8', and H-6/H-5 ( Figure S5 ). The HMQC spectrum exhibited correlations from the aromatic ring proton at 6.80 ppm to C-5, C-5', and C-6', indicating that the aromatic ring protons overlap with three of the aromatic ring carbons ( Figure S6 ). Additionally, the HMBC spectrum showed cross-peaks for 3-OCH 3 /C-3, 3'-OCH 3 /C-3', and 7'-OCH 3 /C-7', indicating the positions of the methoxy groups. The HMBC cross-peaks of H-7/C-8, H-7/C-1, H-7/C-2, H-7/C-6, and H-6/C-7 suggested that C-7 of the alkyne was connected to the A ring. The HMBC cross-peaks of H-7'/C-2', H-7'/C-8', H-7'/C-1', H-7'/C-6', and H-2'/C-7' suggested that C-7' of the methine group was connected to the B ring and a methylene group ( Figure S7 ). Except for the additional methoxy group at C-7', the NMR signals of 8 were similar to those of compound 6 (trans-N-feruloyl-3'-methoxytyramine). Compound 8 was finally identified as trans-N-feruloyl-3', 7'-dimethoxytyramine ( HMBC cross-peaks of H-7/C-8, H-7/C-1, H-7/C-2, H-7/C-6, and H-6/C-7 suggested that C-7 of the alkyne was connected to the A ring. The HMBC cross-peaks of H-7'/C-2', H-7'/C-8', H-7'/C-1', H-7'/C-6', and H-2'/C-7' suggested that C-7' of the methine group was connected to the B ring and a methylene group ( Figure S7 ). Except for the additional methoxy group at C-7', the NMR signals of 8 were similar to those of compound 6 (trans-N-feruloyl-3'-methoxytyramine). Compound 8 was finally identified as trans-N-feruloyl-3', 7'-dimethoxytyramine ( 
Nitric Oxide Production Screening Using Twenty-Two Compounds Isolated from Portulaca oleracea
NO is a major proinflammatory mediator, involved in the pathogenesis of inflammation [33] . During an inflammatory response, the large amount of NO formed by the action of iNOS surpasses 
NO is a major proinflammatory mediator, involved in the pathogenesis of inflammation [33] . During an inflammatory response, the large amount of NO formed by the action of iNOS surpasses the standard physiological amount of NO [34] . A previous study reported that P. oleracea extracts had anti-inflammatory effects and ameliorated inflammatory bowel disease under dextran sulfate sodium-induced colitis by inhibiting NF-κB and MAPK activation [35, 36] . However, the specific active compound responsible for the inflammatory effects remained unclear. Then, we evaluated NO production in LPS-induced RAW 264.7, a mouse macrophage cell line, upon treatment with the 22 compounds isolated from the P. oleracea extract ( Figure 3 ). sodium-induced colitis by inhibiting NF-κB and MAPK activation [35, 36] . However, the specific active compound responsible for the inflammatory effects remained unclear. Then, we evaluated NO production in LPS-induced RAW 264.7, a mouse macrophage cell line, upon treatment with the 22 compounds isolated from the P. oleracea extract ( Figure 3 ).
After screening the impacts of these compounds on NO production, we selected the most potent inhibitor of NO production based on an inhibitory effect of 50% or more as the cut-off. Phenylbutazone (100 μg/mL), one of the nonsteroidal anti-inflammatory drugs, had the best inhibitory effect on nitric oxide of about 50% in RAW 264.7 cells [37] . Of these isolated compounds, compounds that inhibited NO production beyond 50% cut-off under LPS-induced inflammatory conditions were compounds 15 (scinamide C) and 20 (1-carbomethoxy-β-carboline) ( Figure 3A) , and their inhibitory rates were 50.92 ± 0.95% (compound 15) and 53.33 ± 2.49% (compound 20).
In NO production screening in Figure. 3, compounds 3, 5, 6, 9, and 16 showed inhibitory effects of NO production similar to compounds 15 and 20. However, compounds 3, 5, 6, 9, and 16 were already reported in previous studies associated with anti-inflammatory effects or cellular toxicity. Compound 3, derived from Arcangelisia gusanlung and Wolfberry, and compound 6, derived from Wolfberry, were previously reported to inhibit NO production [38, 39] . Compound 5, derived from Solanum nigrum, had an anti-inflammatory effect by inhibition of leukotriene C4 (LTC4) [40] and compound 16, derived from P. oleracea, had a neuroprotective effect by reducing reactive oxygen species (ROS) and inhibiting ERK 1/2 phosphorylation [41] . Compound 9, derived from Hibiscus tiliaceus, had a cytotoxic effect [42] . Thus, we decided to further evaluate compounds 15 and 20. Additionally, to investigate the cellular toxicology after treatment with compounds 15 and 20, we tested cell viability upon treatment with the test compounds at 1 to 100 μM using the MTT assay ( Figure 3B ). Neither compound showed toxicological effects below 100 μM. These results suggested that the major constituents of P. oleracea extract responsible for its ability to inhibit NO production were compounds 15 and 20. After screening the impacts of these compounds on NO production, we selected the most potent inhibitor of NO production based on an inhibitory effect of 50% or more as the cut-off. Phenylbutazone (100 µg/mL), one of the nonsteroidal anti-inflammatory drugs, had the best inhibitory effect on nitric oxide of about 50% in RAW 264.7 cells [37] . Of these isolated compounds, compounds that inhibited NO production beyond 50% cut-off under LPS-induced inflammatory conditions were compounds 15 (scinamide C) and 20 (1-carbomethoxy-β-carboline) ( Figure 3A) , and their inhibitory rates were 50.92 ± 0.95% (compound 15) and 53.33 ± 2.49% (compound 20).
In NO production screening in Figure 3 , compounds 3, 5, 6, 9, and 16 showed inhibitory effects of NO production similar to compounds 15 and 20. However, compounds 3, 5, 6, 9, and 16 were already reported in previous studies associated with anti-inflammatory effects or cellular toxicity. Compound 3, derived from Arcangelisia gusanlung and Wolfberry, and compound 6, derived from Wolfberry, were previously reported to inhibit NO production [38, 39] . Compound 5, derived from Solanum nigrum, had an anti-inflammatory effect by inhibition of leukotriene C 4 (LTC 4 ) [40] and compound 16, derived from P. oleracea, had a neuroprotective effect by reducing reactive oxygen species (ROS) and inhibiting ERK 1/2 phosphorylation [41] . Compound 9, derived from Hibiscus tiliaceus, had a cytotoxic effect [42] . Thus, we decided to further evaluate compounds 15 and 20. Additionally, to investigate the cellular toxicology after treatment with compounds 15 and 20, we tested cell viability upon treatment with the test compounds at 1 to 100 µM using the MTT assay ( Figure 3B ). Neither compound showed toxicological effects below 100 µM. These results suggested that the major constituents of P. oleracea extract responsible for its ability to inhibit NO production were compounds 15 and 20.
Inhibitory Activities of Proinflammatory Mediators by Compounds 15 and 20
iNOS, which is involved in the production of NO, is a novel signaling molecule associated with the MAPK pathway and NF-κB activity in both microglia and macrophage cells [43] . Subsequently, proinflammatory cytokines such as TNF-α, IL-6, and IL-1β are induced by activating nuclear translocation of NF-κB [44] . To investigate intracellular biological evidence of reduced NO level by compound 15 or 20, we evaluated the effect of compounds 15 and 20 on the proinflammatory mediators such as iNOS, TNF-α, IL-6, and IL-1β in LPS-induced macrophages (Figure 4 ). In our results, compound 20 was found to be the most effective inhibitor of iNOS under LPS-induced macrophages based on Western blotting compared with compound 15 ( Figure 4A ). The inhibitory effect of compound 20 (12.5 µM) was similar to that of dexamethasone (positive control, 10 µM). Moreover, we tested proinflammatory cytokines after treatment with compound 15 or 20. Treatment with compound 15 (25 µM) or 20 (12.5 µM) significantly inhibited the proinflammatory cytokine mRNA of TNF-α, IL-6, and IL-1β. There were significantly inhibitory effects of proinflammatory cytokine mRNA of TNF-α, IL-6, and IL-1β after treatment of compound 15 (25 µM) or 20 (12.5 µM). These results suggested that of the alkaloids in P. oleracea extracts (95% EtOH), the major active compound responsible for its anti-inflammatory activity was compound 20 (1-carbomethoxy-beta-carboline). μM) or 20 (12.5 μM) significantly inhibited the proinflammatory cytokine mRNA of TNF-α, IL-6, and IL-1β. There were significantly inhibitory effects of proinflammatory cytokine mRNA of TNF-α, IL-6, and IL-1β after treatment of compound 15 (25 μM) or 20 (12.5 μM) . These results suggested that of the alkaloids in P. oleracea extracts (95% EtOH), the major active compound responsible for its antiinflammatory activity was compound 20 (1-carbomethoxy-beta-carboline). (B) Relative ratio of iNOS versus β-actin was measured using densitometry, and dexamethasone was used as positive control. These graphs represented that compounds 15 and 20 dose-dependently inhibited iNOS using immunoblot analysis. Cells were pretreated with each compound for 2 h and stimulated with LPS (1 µg/mL) for 16 h. Immunoblot analysis was performed in triplicate tests, and results are expressed as means ± SEM. An unpaired Student's t-test was used for statistical analysis. ### p < 0.001 versus Con, * p < 0.05, ** p < 0.01, and *** p < 0.001 versus LPS. (C-E) The mRNA expression levels of TNF-α, IL-6, and IL-1β were measured using quantitative real-time PCR experiment, and these proinflammatory cytokines were significantly diminished by compounds 15 and 21. Cells were preincubated for 2 h with compounds 1 and 3 at concentrations of 5 and 10 µM, respectively, and activated by LPS (1 µg/mL) for 2 h. Results represented as mean ± SEM, and dexamethasone was used as a positive control. # p < 0.05, ## p < 0.01, ### p < 0.001 versus Con, * p < 0.05, ** p < 0.01, and *** p < 0.001 versus LPS. Con: control, LPS: lipopolysaccharide, Dx: dexamethasone.
Portulaca oleracea Inhibits Proinflammatory and Inflammatory Signaling
If compound 20 decreased proinflammatory mediators associated with MAPKs and nuclear translocation of NF-κB with a potency similar to dexamethasone and nonsteroidal anti-inflammatory drugs (NSAIDs) [45] , compound 20 may be a useful therapeutic agent for treating inflammatory diseases with minimal toxic side effects. Then, to further investigate the anti-inflammatory effects associated with the inhibition of NO production and iNOS, we evaluated the major inflammatory signaling pathways, MAPKs, associated with p38, ERK, and JNK and nuclear translocation of NF-κB in LPS-induced murine macrophages, RAW 264.7 cells upon treatment with or without compound 20. Western blotting indicated that pretreatment with compound 20 remarkably disturbed the MAPK signaling pathways associated with JNK, ERK, and p38 under LPS-induced inflammatory conditions in RAW 264.7 cells ( Figure 5A ). The protein expression ratios of p38, ERK, and JNK are shown in Figure 5B -D.
If compound 20 decreased proinflammatory mediators associated with MAPKs and nuclear translocation of NF-κB with a potency similar to dexamethasone and nonsteroidal anti-inflammatory drugs (NSAIDs) [45] , compound 20 may be a useful therapeutic agent for treating inflammatory diseases with minimal toxic side effects. Then, to further investigate the anti-inflammatory effects associated with the inhibition of NO production and iNOS, we evaluated the major inflammatory signaling pathways, MAPKs, associated with p38, ERK, and JNK and nuclear translocation of NF-κB in LPS-induced murine macrophages, RAW 264.7 cells upon treatment with or without compound 20. Western blotting indicated that pretreatment with compound 20 remarkably disturbed the MAPK signaling pathways associated with JNK, ERK, and p38 under LPS-induced inflammatory conditions in RAW 264.7 cells ( Figure 5A ). The protein expression ratios of p38, ERK, and JNK are shown in Figure 5B -D. Subsequently, we tested prevention by pretreatment with compound 20 and qualitatively and quantitatively analyzed NF-κB ( Figure 6 ). First, we determined whether compound 20 suppressed the nuclear translocation of NF-κB. Immunocytochemistry clearly demonstrated that compound 20 reduced the translocation of NF-κB into the nucleus in RAW 264.7 cells ( Figure 6A ). Furthermore, we evaluated nuclear NF-κB and cytosolic IκBα using Western blotting ( Figure 6B ). Compound 20 remarkably ameliorated translocation of nuclear NF-κB by suppressing the degradation of IκBα, similar to dexamethasone ( Figure 6C,D) . A schematic of the mechanism of compound 20 is shown in Figure 6E . These results suggest that compound 20 significantly inhibited the MAPK pathway and Subsequently, we tested prevention by pretreatment with compound 20 and qualitatively and quantitatively analyzed NF-κB ( Figure 6 ). First, we determined whether compound 20 suppressed the nuclear translocation of NF-κB. Immunocytochemistry clearly demonstrated that compound 20 reduced the translocation of NF-κB into the nucleus in RAW 264.7 cells ( Figure 6A ). Furthermore, we evaluated nuclear NF-κB and cytosolic IκBα using Western blotting ( Figure 6B ). Compound 20 remarkably ameliorated translocation of nuclear NF-κB by suppressing the degradation of IκBα, similar to dexamethasone ( Figure 6C,D) . A schematic of the mechanism of compound 20 is shown in Figure 6E 
Materials and Methods

General Experimental Procedures
The structures of isolated compounds were identified by spectroscopic data including 1 H NMR, 13 C NMR, COSY, HMBC, HMQC, HRESIMS, IR, and optical rotation. 1 H, 13 C, and 2D NMR spectra were recorded on a JNM-ECA600 (Jeol, Tokyo, Japan) instrument using TMS as references. High-resolution electrospray ionization mass spectrometry (HRESIMS) was carried out using a Waters SYNAPT G2-Si HDMS spectrometer (Waters, Milford, MA, USA). IR spectra were obtained on a FT/IR-4600 (Jasco, Tokyo, Japan) spectrometer. UV spectra were recorded on a spectraMax M2 ϴ (Molecular Devices, Sunnyvale, CA, USA) spectrophotometer. Optical rotations were measured on a Jasco P-2000 Values are means ± SEM, and an unpaired Student's t-test was used for statistical analysis. # p < 0.05, and ### p < 0.001 versus Con, * p < 0.05, ** p < 0.01, and *** p < 0.001 represented significant differences from the LPS-treated group. Con: control, LPS: lipopolysaccharide, Dx: dexamethasone.
Materials and Methods
General Experimental Procedures
The structures of isolated compounds were identified by spectroscopic data including 1 H NMR, 13 C NMR, COSY, HMBC, HMQC, HRESIMS, IR, and optical rotation. 1 H, 13 C, and 2D NMR spectra were recorded on a JNM-ECA600 (Jeol, Tokyo, Japan) instrument using TMS as references. High-resolution electrospray ionization mass spectrometry (HRESIMS) was carried out using a Waters SYNAPT G2-Si HDMS spectrometer (Waters, Milford, MA, USA). IR spectra were obtained on a FT/IR-4600 (Jasco, Tokyo, Japan) spectrometer. UV spectra were recorded on a spectraMax M 2 θ (Molecular Devices, Sunnyvale, CA, USA) spectrophotometer. Optical rotations were measured on a Jasco P-2000 polarimeter (Jasco). The HPLC analysis was performed using an Agilent 1220 infinity HPLC system (Agilent Technologies, CA, USA) equipped with a quaternary pump.
Plant Material
Dried P. oleracea (20 kg) was purchased from the Kyung-dong market in Seoul, Korea in May 2013. One of the authors (M.-C.R.) performed botanical identification, and a voucher specimen (KRIB-KR2013-003) was deposited at the laboratory of the Immunoregulatory Materials Research Center, Jeonbuk Branch of the Korea Research Institute of Bioscience and Biotechnology.
Extraction and Isolation
Dried powder of P. oleracea (20 kg) was refluxed with 95% EtOH (5 h, 3 × 35 L). After removal of solution under reduced pressure, the 95% EtOH extract (1.5 kg) was suspended in H 2 O and partitioned with n-hexane (3 × 10 L), ethyl acetate (3 × 10 L), and n-butanol (3 × 10 L). Each fraction was evaporated under reduced pressure. The hexane fraction (200 g) was subjected to column chromatography (CC) on silica gel (40 × 10 cm, 200~400 mesh, Merck, Kenilworth, NJ, USA) with a hexane-ethyl acetate gradient solvent system (each 1L, 1:0-0:1, v/v) to yield 16 fractions (POH-POH 16). POH 1, 5, 6, 8, 9, 10 , and 11 were applied to silica gel CC again with a hexane-ethyl acetate gradient solvent system (each 1L, 1:0-0:1, v/v) and subfractions were obtained.
Compound 11 (t R = 45 min, 6.2 mg) was purified from POH 6G (65 mg) by semipreparative HPLC (45% MeCN). The POH 8I (901 mg) was subjected to chromatography on a C 18 The ethyl acetate fraction (150 g) was subjected to column chromatography (CC) on silica gel (40 × 8 cm, 200-400 mesh, Merck, New Jersey, USA) with a chloroform-methanol gradient (each 1L, 1:0-0:1, v/v) to yield nine fractions (POE 1-POE 9). POE 2, 3, 4, 5, 6, and 8 were applied to silica gel CC again and eluted with a chloroform-methanol gradient (100:0-0:100, v/v). POE 1 was subjected to chromatography on a SiO 2 MPLC with a chloroform-methanol gradient (100:0-0:100, v/v) and subfractions were obtained.
The POE 1E (503 mg) was subjected to chromatography on a SiO 2 MPLC using H 2 O and MeOH (1:9-0:10, v/v) to yield 12 subfractions (POE 1E1-POE 1E12). Compound 20 (t R = 54 min, 1.9 mg) was purified from the POE 1E5 (85 mg) by semipreparative HPLC (35% MeCN). The POE 2A (240 mg) was subjected to chromatography on a C 18 Figure S13 and Figure S14 ).
Cell Culture
RAW 264.7 (ATCC TIB-71) cells were cultured in Dulbecco's modified Eagle medium (DMEM) and RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 U/mL penicillin, and 100 mg/mL streptomycin sulfate. Cell were maintained at 37 • C in humidified air with 5% CO 2 .
Measurement of NO Contents and Cell Cytotoxicity
RAW 264.7 (ATCC TIB-71) cells were cultured in Dulbecco's modified Eagle medium (DMEM) and NO assay was carried out for measurements of NO release using previously reported method [46] . Briefly, RAW 264.7 cells were plated at 1 × 10 5 cell density in a 96-well microplate and cultured for 24 h. Compounds were pretreated with increasing dose concentrations (0.5, 1, 5, 10, 25, 50, and 100 µM), and then stimulated with LPS (1 µg/mL, Sigma-Aldrich, St. Louis, MO, USA) for 18 h. The mixture of cell supernatant (100 µL) and Griess reagent [1% sulfanilamide + 0.1% N-(1-naphthyl)ethylenediamine (Sigma-Aldrich)] in 5% phosphoric acid was recorded at 550 nm using a microplate reader (Varioskan LUX, Thermo Fisher Scientific Inc., Waltham, MA, USA). RAW 264.7 cell cytotoxicity was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay [47] .
Immunoblot Analysis
The whole cell lysate was extracted using Cell Lysis Buffer (Cell Signaling Technology, Beverly, MA, USA). The cytosolic and nuclear extracts were prepared using an NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. Immunoblot analysis was performed as previously described [48] . After transfer to nitrocellulose (NC) membrane, the blocking membrane with 5% skimmed milk powder was incubated overnight at 4 • C with primary antibody, including anti-phospho-JNK (1:1000), anti-JNK (1:1000), anti-phospho-p38 (1:1000), anti-p38 (1:1000), anti-phospho-ERK (1:1000), anti-ERK (1:1000), anti-p65 (1:1000), anti-IκBα (1:1000), anti-iNOS (1:1000), and anti-β-actin antibodies (Cell Signaling Technology, Beverly, MA, USA). The membranes were then incubated with a horseradish peroxide-conjugated anti-rabbit secondary antibody (1:5000) at room temperature. The band densities were calculated with Quantity One software (Bio-Rad Laboratories, Hercules, CA, USA).
Real-Time PCR Using TaqMan Probe
Total RNA was extracted from RAW 264.7 cells using the TaKaRa MiniBEST Universal RNA Extraction Kit following the manufacturer's instructions (TaKaRa Bio Inc., Shiga, Japan). The complementary DNA (cDNA) was synthesized from 1 µg of the total RNA using a PrimeScript 1st strand cDNA synthesis kit (Takara Bio Inc. Japan). Quantitative real-time PCR (qPCR) of Il1bβ (Mm00434228_m1), Il6 (Mm00446190_m1), and Tnf (Mm00443258_m1) was performed with a TaqMan Gene Expression Assay Kit (Thermo Fisher Scientific, San Jose, CA, USA). To normalize the gene expression, an 18S rRNA endogenous control (Applied Biosystems, Foster City, CA, USA) was used. The qPCR was employed to verify the mRNA expression using a Step-One Plus Real-Time PCR system. To quantify mRNA expression, TaqMan mRNA assay was performed according to the manufacturer's protocol (Applied Biosystems) [49] . PCR amplification was analyzed using the comparative ∆∆CT method.
Immunocytochemistry
RAW 264.7 (1 × 10 6 per well) cells were seeded on collagen-coated coverslips in six-well plates and incubated overnight. Then, the cells were pretreated with compound 20 (12.5 µM) or dexamethasone (10 µM) for 2 h. Then, the coverslips were washed with phosphate-buffered saline (PBS) and fixed with ice-cold methanol for 10 min at room temperature. After blocking with 1% bovine serum albumin (BSA) in PBS containing 0.1% Tween 20 (PBST) for 30 min, the coverslips were incubated overnight with an anti-p65 NF-κB antibody in a humidified chamber at 4 • C, followed by coincubation with an FITC-labeled anti-rabbit IgG antibody in a 37 • C humidified chamber for 60 min in the dark. The coverslips were sealed and stained with DAPI by using ProLong Gold antifade reagent with DAPI (Thermo Fisher Scientific, Waltham, MA, USA). Immunofluorescence images were obtained using an Olympus IX73 microscope with cellSens software (Olympus, Center Valley, PA, USA) [47] .
Statistical Analysis
GraphPad Prism 5 software (GraphPad software, San Diego, CA, USA) was used for the statistical analysis of the experimental results. Each experiment, including NO assay, MTT assay, immunoblot, and real-time PCR, was performed independently three times, and these data represent the mean ± standard error of the mean (SEM). For comparisons between the control and LPS-treated groups, the unpaired t-test or Mann-Whitney U-test was used according to the data distribution. The statistical significance of each value was measured by the unpaired Student's t-test or Mann-Whitney U-test. * p < 0.05, ** p < 0.01, and *** p < 0.001 were considered significant.
Conclusions
The 1-carbomethoxy-β-carboline (compound 20), which has an alkaloid structure as an active compound responsible for the anti-inflammatory activity of P. oleracea extract (95%), disturbed one of the major intracellular inflammatory signaling pathways associated with MAPKs and suppressed the nuclear translocation of NF-κB, decreasing proinflammatory mediators such as iNOS, TNF-α, IL-6, and IL-1β. These results indicate that P. oleracea extract and its components, specifically alkaloid compound 20, may be useful and safe therapeutic agents for treating the painful symptoms of inflammatory diseases such as rheumatoid arthritis, allergic asthma, and atopic dermatitis as an alternative to NSAIDs and dexamethasone. Further studies are necessary to improve the extraction efficiency of compound 20 and determine the structural characteristics responsible for its bioactivity and to evaluate better clinical mimic experiments such as using human monocytes rather than the single mouse cell line, RAW 264.7.
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